Screener
Surgery Partners, Inc. SGRY Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $848.9M+2.7% | $810.9M+4.5% | $885M+2.4% | $821.5M+6.6% | $826.2M+8.4% | ||
| $36.3M+0.6% | $39.3M+9.2% | $23.7M-34.2% | $22.4M-23.3% | $36.1M-10.4% | ||
| $746.8M+4.5% | $745.1M+4.3% | $774.8M+5.1% | $715.8M+0.9% | $714.5M+5.5% | ||
| $658.7M+4.5% | $650.7M+6.0% | $672.8M+6.7% | $626.2M+5.6% | $630.6M+8.2% | ||
| $102.1M-8.6% | $65.8M+6.3% | $110.2M-13.3% | $105.7M+73.6% | $111.7M+31.7% | ||
| 12%-1.5pp | 8.1%+0.1pp | 12.5%-2.3pp | 12.9%+5.0pp | 13.5%+2.4pp | ||
| -$69.8M-2.8% | -$69.1M-11.1% | -$67.6M-27.8% | -$74.9M-49.8% | -$67.9M-31.8% | ||
| $2.6M+336% | -$1.2M— | $13.6M-88.7% | $5.5M+22.2% | -$1.1M-122% | ||
| -$15M-500% | -$35.9M+4.8% | -$15M+86.2% | -$22.7M+28.4% | -$2.5M+83.9% | ||
| -1.8%-1.5pp | -4.4%+0.4pp | -1.7%+10.9pp | -2.8%+1.4pp | -0.3%+1.7pp | ||
| -$0.12-500% | -$0.28+6.7% | -$0.11+87.2% | -$0.18+28.0% | -$0.02+83.3% | ||
| $141.4M-7.0% | $104.3M+6.2% | $170.1M+5.7% | $145.2M+30.7% | $152M+27.1% | ||
| 16.7%-1.7pp | 12.9%+0.2pp | 19.2%+0.6pp | 17.7%+3.3pp | 18.4%+2.7pp | ||
| $102.1M-8.6% | $65.8M+6.3% | $110.2M-13.3% | $105.7M+73.6% | $111.7M+31.7% |
FAQ
- What is Surgery Partners, Inc.'s revenue?
- Surgery Partners, Inc. (SGRY) generated $3.4B in revenue over the trailing twelve months, up 4.0% year over year.
- Is Surgery Partners, Inc. profitable?
- Surgery Partners, Inc. is not currently profitable: it reported a net loss of $88.6M over the trailing twelve months, a -2.6% net margin.
- What are Surgery Partners, Inc.'s profit margins?
- Gross margin is 23.1% and operating margin is 11.4%, with a -2.6% net margin.
- What is Surgery Partners, Inc.'s earnings per share?
- Surgery Partners, Inc.'s diluted EPS over the trailing twelve months is $-0.69.
- Where does Surgery Partners, Inc.'s income statement data come from?
- Every line is extracted from Surgery Partners, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
